Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Cash Flow Quality Index

Latest as of September 2025: 0.18x

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a Cash Flow Quality Index of 0.18x as of September 2025. Operating cash flow of $137.91K is below net income of $785.09K, suggesting accrual-heavy earnings not yet converted to cash. Also explore DMAA current and non-current assets for the complete picture of this company's asset base.

Cash Flow Quality Index

0.18x

Operating CF / Net Income

Operating Cash Flow

$137.91K

USD

Net Income

$785.09K

USD

Data as of

Sep 2025

Most recent filing

Annual Cash Flow Quality Index for Drugs Made In America Acquisition Corp. Ordinary Shares (None–None)

Year-by-year earnings quality comparison for Drugs Made In America Acquisition Corp. Ordinary Shares. For live market cap and the full company financial profile, see DMAA company net worth.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.